GENB - CIK 0002100782
The table below shows Generate Biomedicines, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 |
|---|---|---|
| Operating cash flow | -$80.39M | -$53.18M |
| Capital expenditure | $3.78M | $751.00K |
| Investing cash flow | -$259.93M | $75.53M |
| Dividends paid | - | - |
| Stock buybacks | - | - |
| Financing cash flow | $378.89M | $20.56M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.